by McDermott + Bull | Sep 22, 2026 | Ken Dropiewski, Ken Dropiewski Placement Announcement, Michael Matranga
McDermott + Bull has successfully placed Rhonda Robb as Chief Executive Officer at ArchCath. In this role, Rhonda will lead the company through its next phase of growth, with responsibility for advancing its financing, clinical, regulatory, and commercialization...
by McDermott + Bull | Sep 21, 2026 | Placement Announcement, Healthcare + Life Sciences, Healthcare + Life Sciences Placement Announcement, Jake Vander Zanden, Jake Vander Zanden Placement Announcement, Michael Matranga
McDermott + Bull has successfully placed Stephanie Beyer as Director of Compliance at Embla Medical. In this role, Stephanie will lead and evolve the company’s compliance program, with a focus on risk assessment, regulatory oversight, and the development of scalable...
by McDermott + Bull | Sep 21, 2026 | Placement Announcement, Healthcare + Life Sciences, Healthcare + Life Sciences Placement Announcement, Jake Vander Zanden, Jake Vander Zanden Placement Announcement, Michael Matranga
McDermott + Bull has successfully placed Maria Penate as Director of Compliance at ClinNEXUS. In this role, Maria will be responsible for leading the company’s risk, compliance, and quality strategy, including strengthening operational controls, formalizing risk...
by McDermott + Bull | Aug 11, 2026 | Ken Dropiewski, Ken Dropiewski Placement Announcement, Michael Matranga
McDermott + Bull has successfully placed David Vort as Chief Commercial Officer at Caristo Diagnostics. In this role, David will lead the company’s U.S. commercial strategy, with responsibility for accelerating revenue, advancing market access and reimbursement...
by McDermott + Bull | Jul 6, 2026 | Placement Announcement, Healthcare + Life Sciences, Healthcare + Life Sciences Placement Announcement, Jake Vander Zanden, Jake Vander Zanden Placement Announcement, Michael Matranga
McDermott + Bull has successfully placed John Stamatopoulos as Chief Growth Officer at ClinNEXUS. In this role, John will lead the company’s payer-facing commercial strategy, partnering closely with the executive leadership team to build and scale its revenue...
by McDermott + Bull | Apr 21, 2026 | Placement Announcement, Healthcare + Life Sciences, Healthcare + Life Sciences Placement Announcement, Jake Vander Zanden, Jake Vander Zanden Placement Announcement, Michael Matranga
McDermott + Bull has successfully placed Abraham Sabbagh as Chief Financial Officer at Biogas Engineering. In this role, Abraham will be responsible for leading the company’s financial strategy, including capital markets initiatives, project finance structuring, and...
